Material Event (Form 8-K)

8.01 Other Events.

On April 14, 2026, Integrated BioPharma, Inc. (the "Company") and Manhattan Drug Company, Inc. ("MDC"), a wholly owned subsidiary of the Company (collectively, the "Companies"), received notification from PNC Bank, National Association ("PNC") that the Companies' Expiration Date of the Line of Credit with PNC, as set forth in a promissory note executed and delivered by the Companies to PNC dated April 15, 2025, has been extended from April 15, 2026 to July 14, 2026, or such late date as may, in PNC's sole discretion, be designated by PNC by written notice from PNC to the Companies, effective on April 16, 2026.